A prospective naturalistic study of antidepressant-induced jitteriness/anxiety syndrome

Tsuyoto HaradaDepartment of Psychiatry, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan

Ken InadaDepartment of Psychiatry, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan

Kazuo YamadaDepartment of Psychiatry, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan

Kaoru SakamotoDepartment of Psychiatry, Tokyo Women’s Medical University School of Medicine, Tokyo, JapanCorrespondence[email protected]

Jun IshigookaDepartment of Psychiatry, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan

Pages 2115-2121 | Published online: 10 Nov 2014

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

KingRARiddleMAChappellPBEmergence of self-destructive phenomena in children and adolescents during fluoxetine treatmentJ Am Acad Child Adolesc Psychiatry19913021791862016219
PubMed Web of Science ®Google Scholar
FriedmanEHTricyclic-induced activation/jitterinessJ Clin Psychopharmacol19911163943951770162
PubMed Web of Science ®Google Scholar
JacksonCWLydiardRBTwo cases of activation/jitteriness associated with TCAsJ Clin Psychopharmacol19901064394402286716
PubMed Web of Science ®Google Scholar
PohlRYeraganiVKOrtizARaineyJMJrGershonSResponse of tricyclic-induced jitteriness to a phenothiazine in two patientsJ Clin Psychiatry19864784273733676
PubMed Web of Science ®Google Scholar
YeraganiVKPohlRBalonRTricyclics, akathisia, and jitterinessJ Clin Psychopharmacol1988842953209722
PubMed Web of Science ®Google Scholar
YeraganiVKPohlRBalonRKulkarniAKeshavanMLow serum iron levels and tricyclic antidepressant-induced jitterinessJ Clin Psychopharmacol1989964474482592591
PubMed Web of Science ®Google Scholar
US Food Drug AdministrationReports of suicidality in pediatric patients being treated with antidepressant medications for major depressive disorder (MDD)2003 Available from: http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm168828.htmAccessed October 24, 2014
Google Scholar
US Food Drug AdministrationWorsening depression and suicidality in patients being treated with antidepressants2004 Available from: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationfor-PatientsandProviders/ucm161696.htmAccessed October 24, 2014
Google Scholar
JuurlinkDNMamdaniMMKoppARedelmeierDAThe risk of suicide with selective serotonin reuptake inhibitors in the elderlyAm J Psychiatry2006163581382116648321
PubMed Web of Science ®Google Scholar
SimonGESavarinoJSuicide attempts among patients starting depression treatment with medications or psychotherapyAm J Psychiatry200716471029103417606654
PubMed Web of Science ®Google Scholar
TondoLLepriBBaldessariniRJSuicidal status during antidepressant treatment in 789 Sardinian patients with major affective disorderActa Psychiatr Scand2008118210611518397362
PubMed Web of Science ®Google Scholar
SimonGESavarinoJOperskalskiBWangPSSuicide risk during antidepressant treatmentAm J Psychiatry20061631414716390887
PubMed Web of Science ®Google Scholar
HammadTALaughrenTRacoosinJSuicidality in pediatric patients treated with antidepressant drugsArch Gen Psychiatry200663333233916520440
PubMed Web of Science ®Google Scholar
RotenbergVSFunctional brain asymmetry as a determinative factor in the treatment of depression: theoretical implicationsProg Neuropsychopharmacol Biol Psychiatry20083281772177718775761
PubMed Web of Science ®Google Scholar
RotenbergVSSearch activity concept: relationship between behavior, health and brain functionsActivitas Nervosa Superior20095111244
Google Scholar
TakeshimaMOkaTAssociation between the so-called “activation syndrome” and bipolar II disorder, a related disorder, and bipolar suggestive features in outpatients with depressionJ Affect Disord2013151119620223790740
PubMed Web of Science ®Google Scholar
KrausJEHorriganJPCarpenterDJFongRBarrettPSDaviesJTClinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapyJ Affect Disord20101201–3404719439363
PubMed Web of Science ®Google Scholar
SinclairLIChristmasDMHoodSDAntidepressant-induced jitteriness/anxiety syndrome: systematic reviewBr J Psychiatry2009194648349019478285
PubMed Web of Science ®Google Scholar
BeasleyCMJrPotvinJHFluoxetine: activating and sedating effectsInt Clin Psychopharmacol1993842712758277147
PubMed Web of Science ®Google Scholar
AmsterdamJDHornig-RohanMMaislinGEfficacy of alprazolam in reducing fluoxetine-induced jitteriness in patients with major depressionJ Clin Psychiatry19945593944007929020
PubMed Web of Science ®Google Scholar
HaradaTSakamotoKIshigookaJIncidence and predictors of activation syndrome induced by antidepressantsDepress Anxiety200825121014101918781664
PubMed Web of Science ®Google Scholar
AkiskalHSHantoucheEGAllilaireJFValidating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II)J Affect Disord2003731–2657412507739
PubMed Web of Science ®Google Scholar
FriedmanRALeonACExpanding the black box – depression, antidepressants, and the risk of suicideN Engl J Med2007356232343234617485726
PubMed Web of Science ®Google Scholar
SchneeweissSPatrickARSolomonDHComparative safety of antidepressant agents for children and adolescents regarding suicidal actsPediatrics2010125587688820385637
PubMed Web of Science ®Google Scholar
SchneeweissSPatrickARSolomonDHVariation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years’ dataArch Gen Psychiatry201067549750620439831
PubMed Web of Science ®Google Scholar
HammadTAResults of the analysis of suicidality in pediatric trials of newer antidepressants2004 Available from: http://www.fda.gov/ohrms/dockets/ac/04/slides/2004-4065S1_08_FDA-Hammad.pptAccessed September 19, 2014
Google Scholar
YeraganiVKPohlRBalonRRameshCWeinbergPImipramine-induced jitteriness and decreased serum iron levelsNeuropsychobiology19922518101603294
PubMed Web of Science ®Google Scholar
BeasleyCMJrSaylerMEWeissAMPotvinJHFluoxetine: activating and sedating effects at multiple fixed dosesJ Clin Psychopharmacol19921253283331479050
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

A prospective naturalistic study of antidepressant-induced jitteriness/anxiety syndrome

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A prospective naturalistic study of antidepressant-induced jitteriness/anxiety syndrome

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date